ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
UCB Announces Alzheimer's Disease Treatment Coloration with Roche
August 05, 2020UCB announced an agreement to enter into a world-wide, exclusive license agreement with Roche and Genentech, a member of the Roche Group, for the global development and commercialization of UCB0107 in Alzheimer's Disease (AD). -
Roche and UCB partner to develop antibody therapy for Alzheimer’s
July 31, 2020Roche and its unit Genentech have agreed to a global, exclusive licence agreement with Belgian company UCB to develop and commercialise an antibody treatment, UCB0107, for Alzheimer’s disease.
Pharma Sources Insight January 2025
